nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Paclitaxel—Docetaxel—melanoma	0.0175	1	CbGdCrCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—AURKA—melanoma	0.00434	0.038	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—RAI1—melanoma	0.00359	0.0315	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—E2F1—melanoma	0.00337	0.0295	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—PCNA—melanoma	0.00318	0.0279	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—CDK2—melanoma	0.00291	0.0255	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FASN—melanoma	0.00289	0.0253	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—PKMYT1—melanoma	0.00275	0.0241	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—melanoma	0.00235	0.0206	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—APC—melanoma	0.0023	0.0201	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—melanoma	0.00216	0.0189	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—ARNT—melanoma	0.00214	0.0187	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PAX4—melanoma	0.00206	0.0181	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.00202	0.0177	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—melanoma	0.00197	0.0173	CbGpPWpGaD
Moxifloxacin—Gatifloxacin—ALB—melanoma	0.00191	0.402	CrCbGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—melanoma	0.00166	0.0146	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.00163	0.0143	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—melanoma	0.0016	0.014	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—melanoma	0.00148	0.013	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.00145	0.0127	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.00145	0.0127	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—melanoma	0.00139	0.0122	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.00134	0.0118	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.0013	0.0114	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—melanoma	0.00127	0.0111	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—melanoma	0.00124	0.0109	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.00123	0.0108	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—melanoma	0.00123	0.0108	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—REC8—melanoma	0.00123	0.0108	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—MYC—melanoma	0.0012	0.0105	CbGpPWpGaD
Moxifloxacin—Sparfloxacin—ABCB1—melanoma	0.00119	0.251	CrCbGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—melanoma	0.00117	0.0103	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—EGFR—melanoma	0.00117	0.0103	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—melanoma	0.00107	0.0094	CbGpPWpGaD
Moxifloxacin—Anaemia—Dactinomycin—melanoma	0.00105	0.00122	CcSEcCtD
Moxifloxacin—Liver function test abnormal—Docetaxel—melanoma	0.00105	0.00122	CcSEcCtD
Moxifloxacin—Vomiting—Vemurafenib—melanoma	0.00105	0.00121	CcSEcCtD
Moxifloxacin—Dry skin—Docetaxel—melanoma	0.00104	0.00121	CcSEcCtD
Moxifloxacin—Chest pain—Bleomycin—melanoma	0.00104	0.0012	CcSEcCtD
Moxifloxacin—Myalgia—Bleomycin—melanoma	0.00104	0.0012	CcSEcCtD
Moxifloxacin—Abdominal pain upper—Docetaxel—melanoma	0.00104	0.0012	CcSEcCtD
Moxifloxacin—Orthostatic hypotension—Docetaxel—melanoma	0.00104	0.0012	CcSEcCtD
Moxifloxacin—Rash—Vemurafenib—melanoma	0.00104	0.0012	CcSEcCtD
Moxifloxacin—Mental disorder—Temozolomide—melanoma	0.00104	0.0012	CcSEcCtD
Moxifloxacin—Dermatitis—Vemurafenib—melanoma	0.00104	0.0012	CcSEcCtD
Moxifloxacin—Back pain—Carmustine—melanoma	0.00103	0.00119	CcSEcCtD
Moxifloxacin—Headache—Vemurafenib—melanoma	0.00103	0.00119	CcSEcCtD
Moxifloxacin—Malnutrition—Temozolomide—melanoma	0.00103	0.00119	CcSEcCtD
Moxifloxacin—Erythema—Temozolomide—melanoma	0.00103	0.00119	CcSEcCtD
Moxifloxacin—Breast disorder—Docetaxel—melanoma	0.00103	0.00119	CcSEcCtD
Moxifloxacin—Discomfort—Bleomycin—melanoma	0.00103	0.00119	CcSEcCtD
Moxifloxacin—Malaise—Dactinomycin—melanoma	0.00103	0.00119	CcSEcCtD
Moxifloxacin—Cramp muscle—Docetaxel—melanoma	0.00102	0.00119	CcSEcCtD
Moxifloxacin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00102	0.00119	CcSEcCtD
Moxifloxacin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00102	0.00119	CcSEcCtD
Moxifloxacin—Leukopenia—Dactinomycin—melanoma	0.00102	0.00118	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—melanoma	0.00101	0.00888	CbGpPWpGaD
Moxifloxacin—Dysgeusia—Temozolomide—melanoma	0.00101	0.00117	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—INCENP—melanoma	0.00101	0.00884	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PKMYT1—melanoma	0.00101	0.00884	CbGpPWpGaD
Moxifloxacin—Confusional state—Bleomycin—melanoma	0.001	0.00116	CcSEcCtD
Moxifloxacin—Vision blurred—Carmustine—melanoma	0.001	0.00116	CcSEcCtD
Moxifloxacin—Alanine aminotransferase increased—Docetaxel—melanoma	0.001	0.00116	CcSEcCtD
Moxifloxacin—Tremor—Carmustine—melanoma	0.000999	0.00116	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Bleomycin—melanoma	0.000997	0.00115	CcSEcCtD
Moxifloxacin—Oedema—Bleomycin—melanoma	0.000997	0.00115	CcSEcCtD
Moxifloxacin—Back pain—Temozolomide—melanoma	0.000996	0.00115	CcSEcCtD
Moxifloxacin—Anaemia—Carmustine—melanoma	0.000985	0.00114	CcSEcCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—melanoma	0.000983	0.00862	CbGpPWpGaD
Moxifloxacin—Dysphagia—Docetaxel—melanoma	0.000983	0.00114	CcSEcCtD
Moxifloxacin—Agitation—Carmustine—melanoma	0.00098	0.00113	CcSEcCtD
Moxifloxacin—Nausea—Vemurafenib—melanoma	0.000977	0.00113	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Bleomycin—melanoma	0.000976	0.00113	CcSEcCtD
Moxifloxacin—Vision blurred—Temozolomide—melanoma	0.000971	0.00112	CcSEcCtD
Moxifloxacin—Myalgia—Dactinomycin—melanoma	0.00097	0.00112	CcSEcCtD
Moxifloxacin—Bronchospasm—Docetaxel—melanoma	0.000967	0.00112	CcSEcCtD
Moxifloxacin—Tremor—Temozolomide—melanoma	0.000965	0.00112	CcSEcCtD
Moxifloxacin—Discomfort—Dactinomycin—melanoma	0.000958	0.00111	CcSEcCtD
Moxifloxacin—Angina pectoris—Docetaxel—melanoma	0.000958	0.00111	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Temozolomide—melanoma	0.000956	0.00111	CcSEcCtD
Moxifloxacin—Leukopenia—Carmustine—melanoma	0.000954	0.0011	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—melanoma	0.000952	0.00835	CbGpPWpGaD
Moxifloxacin—Anaemia—Temozolomide—melanoma	0.000952	0.0011	CcSEcCtD
Moxifloxacin—Anorexia—Bleomycin—melanoma	0.00095	0.0011	CcSEcCtD
Moxifloxacin—Agitation—Temozolomide—melanoma	0.000947	0.0011	CcSEcCtD
Moxifloxacin—Angioedema—Temozolomide—melanoma	0.000941	0.00109	CcSEcCtD
Moxifloxacin—Pancytopenia—Docetaxel—melanoma	0.000934	0.00108	CcSEcCtD
Moxifloxacin—Hypotension—Bleomycin—melanoma	0.000931	0.00108	CcSEcCtD
Moxifloxacin—Oedema—Dactinomycin—melanoma	0.00093	0.00108	CcSEcCtD
Moxifloxacin—Malaise—Temozolomide—melanoma	0.000929	0.00108	CcSEcCtD
Moxifloxacin—Vertigo—Temozolomide—melanoma	0.000926	0.00107	CcSEcCtD
Moxifloxacin—Convulsion—Carmustine—melanoma	0.000924	0.00107	CcSEcCtD
Moxifloxacin—Leukopenia—Temozolomide—melanoma	0.000922	0.00107	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—GNA11—melanoma	0.000922	0.00809	CbGpPWpGaD
Moxifloxacin—Hypertension—Carmustine—melanoma	0.00092	0.00107	CcSEcCtD
Moxifloxacin—Neutropenia—Docetaxel—melanoma	0.000919	0.00106	CcSEcCtD
Moxifloxacin—Palpitations—Temozolomide—melanoma	0.00091	0.00105	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Dactinomycin—melanoma	0.00091	0.00105	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000908	0.00105	CcSEcCtD
Moxifloxacin—Chest pain—Carmustine—melanoma	0.000908	0.00105	CcSEcCtD
Moxifloxacin—Myalgia—Carmustine—melanoma	0.000908	0.00105	CcSEcCtD
Moxifloxacin—Anxiety—Carmustine—melanoma	0.000904	0.00105	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—PKMYT1—melanoma	0.000901	0.00791	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—INCENP—melanoma	0.000901	0.00791	CbGpPWpGaD
Moxifloxacin—Cough—Temozolomide—melanoma	0.000899	0.00104	CcSEcCtD
Moxifloxacin—Paraesthesia—Bleomycin—melanoma	0.000895	0.00104	CcSEcCtD
Moxifloxacin—Weight increased—Docetaxel—melanoma	0.000895	0.00104	CcSEcCtD
Moxifloxacin—Convulsion—Temozolomide—melanoma	0.000893	0.00103	CcSEcCtD
Moxifloxacin—Hypertension—Temozolomide—melanoma	0.000889	0.00103	CcSEcCtD
Moxifloxacin—Dyspnoea—Bleomycin—melanoma	0.000889	0.00103	CcSEcCtD
Moxifloxacin—Anorexia—Dactinomycin—melanoma	0.000886	0.00103	CcSEcCtD
Moxifloxacin—Pneumonia—Docetaxel—melanoma	0.000882	0.00102	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—melanoma	0.00088	0.00772	CbGpPWpGaD
Moxifloxacin—Confusional state—Carmustine—melanoma	0.000877	0.00102	CcSEcCtD
Moxifloxacin—Arthralgia—Temozolomide—melanoma	0.000877	0.00102	CcSEcCtD
Moxifloxacin—Myalgia—Temozolomide—melanoma	0.000877	0.00102	CcSEcCtD
Moxifloxacin—Infestation NOS—Docetaxel—melanoma	0.000877	0.00101	CcSEcCtD
Moxifloxacin—Infestation—Docetaxel—melanoma	0.000877	0.00101	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—E2F1—melanoma	0.000874	0.00767	CbGpPWpGaD
Moxifloxacin—Anxiety—Temozolomide—melanoma	0.000874	0.00101	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000871	0.00101	CcSEcCtD
Moxifloxacin—Oedema—Carmustine—melanoma	0.00087	0.00101	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000869	0.00101	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—HDAC2—melanoma	0.000867	0.0076	CbGpPWpGaD
Moxifloxacin—Discomfort—Temozolomide—melanoma	0.000867	0.001	CcSEcCtD
Moxifloxacin—Decreased appetite—Bleomycin—melanoma	0.000866	0.001	CcSEcCtD
Moxifloxacin—Acute coronary syndrome—Docetaxel—melanoma	0.000864	0.001	CcSEcCtD
Moxifloxacin—Renal failure—Docetaxel—melanoma	0.000862	0.000998	CcSEcCtD
Moxifloxacin—Myocardial infarction—Docetaxel—melanoma	0.000859	0.000995	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Docetaxel—melanoma	0.000859	0.000995	CcSEcCtD
Moxifloxacin—Dry mouth—Temozolomide—melanoma	0.000858	0.000993	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—GNAQ—melanoma	0.000857	0.00752	CbGpPWpGaD
Moxifloxacin—Jaundice—Docetaxel—melanoma	0.000854	0.000989	CcSEcCtD
Moxifloxacin—Stomatitis—Docetaxel—melanoma	0.000854	0.000989	CcSEcCtD
Moxifloxacin—Pain—Bleomycin—melanoma	0.000852	0.000987	CcSEcCtD
Moxifloxacin—Conjunctivitis—Docetaxel—melanoma	0.000852	0.000987	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Carmustine—melanoma	0.000852	0.000986	CcSEcCtD
Moxifloxacin—Tachycardia—Carmustine—melanoma	0.000849	0.000983	CcSEcCtD
Moxifloxacin—Confusional state—Temozolomide—melanoma	0.000848	0.000981	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000847	0.00098	CcSEcCtD
Moxifloxacin—Oedema—Temozolomide—melanoma	0.000841	0.000973	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Temozolomide—melanoma	0.000841	0.000973	CcSEcCtD
Moxifloxacin—Levofloxacin—ABCB1—melanoma	0.000837	0.176	CrCbGaD
Moxifloxacin—Anorexia—Carmustine—melanoma	0.000829	0.00096	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Docetaxel—melanoma	0.000829	0.00096	CcSEcCtD
Moxifloxacin—Epistaxis—Docetaxel—melanoma	0.000827	0.000957	CcSEcCtD
Moxifloxacin—Nervous system disorder—Temozolomide—melanoma	0.000824	0.000955	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—PCNA—melanoma	0.000824	0.00723	CbGpPWpGaD
Moxifloxacin—Thrombocytopenia—Temozolomide—melanoma	0.000823	0.000953	CcSEcCtD
Moxifloxacin—Feeling abnormal—Bleomycin—melanoma	0.000821	0.000951	CcSEcCtD
Moxifloxacin—Agranulocytosis—Docetaxel—melanoma	0.000818	0.000947	CcSEcCtD
Moxifloxacin—Skin disorder—Temozolomide—melanoma	0.000817	0.000945	CcSEcCtD
Moxifloxacin—Hypotension—Carmustine—melanoma	0.000813	0.000941	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Temozolomide—melanoma	0.000813	0.000941	CcSEcCtD
Moxifloxacin—Ciprofloxacin—ABCB1—melanoma	0.000808	0.17	CrCbGaD
Moxifloxacin—Decreased appetite—Dactinomycin—melanoma	0.000808	0.000936	CcSEcCtD
Moxifloxacin—Fatigue—Dactinomycin—melanoma	0.000801	0.000928	CcSEcCtD
Moxifloxacin—Anorexia—Temozolomide—melanoma	0.000801	0.000928	CcSEcCtD
Moxifloxacin—Pain—Dactinomycin—melanoma	0.000795	0.00092	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Carmustine—melanoma	0.000793	0.000918	CcSEcCtD
Moxifloxacin—Urticaria—Bleomycin—melanoma	0.000792	0.000917	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—NGFR—melanoma	0.000791	0.00694	CbGpPWpGaD
Moxifloxacin—Haemoglobin—Docetaxel—melanoma	0.000791	0.000916	CcSEcCtD
Moxifloxacin—Rhinitis—Docetaxel—melanoma	0.000789	0.000913	CcSEcCtD
Moxifloxacin—Body temperature increased—Bleomycin—melanoma	0.000788	0.000912	CcSEcCtD
Moxifloxacin—Haemorrhage—Docetaxel—melanoma	0.000787	0.000911	CcSEcCtD
Moxifloxacin—Hepatitis—Docetaxel—melanoma	0.000787	0.000911	CcSEcCtD
Moxifloxacin—Insomnia—Carmustine—melanoma	0.000787	0.000911	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Docetaxel—melanoma	0.000783	0.000907	CcSEcCtD
Moxifloxacin—Paraesthesia—Carmustine—melanoma	0.000781	0.000904	CcSEcCtD
Moxifloxacin—Pharyngitis—Docetaxel—melanoma	0.000781	0.000904	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Docetaxel—melanoma	0.000777	0.0009	CcSEcCtD
Moxifloxacin—Dyspnoea—Carmustine—melanoma	0.000776	0.000898	CcSEcCtD
Moxifloxacin—Oedema peripheral—Docetaxel—melanoma	0.000775	0.000898	CcSEcCtD
Moxifloxacin—Somnolence—Carmustine—melanoma	0.000773	0.000895	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Docetaxel—melanoma	0.000773	0.000895	CcSEcCtD
Moxifloxacin—Urethral disorder—Docetaxel—melanoma	0.000771	0.000893	CcSEcCtD
Moxifloxacin—Feeling abnormal—Dactinomycin—melanoma	0.000766	0.000887	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000766	0.000887	CcSEcCtD
Moxifloxacin—Insomnia—Temozolomide—melanoma	0.00076	0.00088	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Dactinomycin—melanoma	0.00076	0.00088	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—POT1—melanoma	0.000759	0.00665	CbGpPWpGaD
Moxifloxacin—Visual impairment—Docetaxel—melanoma	0.000758	0.000878	CcSEcCtD
Moxifloxacin—Decreased appetite—Carmustine—melanoma	0.000756	0.000876	CcSEcCtD
Moxifloxacin—Paraesthesia—Temozolomide—melanoma	0.000755	0.000874	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—melanoma	0.000754	0.00661	CbGpPWpGaD
Moxifloxacin—Gastrointestinal disorder—Carmustine—melanoma	0.000751	0.00087	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—melanoma	0.000751	0.00658	CbGpPWpGaD
Moxifloxacin—Dyspnoea—Temozolomide—melanoma	0.00075	0.000868	CcSEcCtD
Moxifloxacin—Somnolence—Temozolomide—melanoma	0.000747	0.000865	CcSEcCtD
Moxifloxacin—Erythema multiforme—Docetaxel—melanoma	0.000744	0.000861	CcSEcCtD
Moxifloxacin—Pain—Carmustine—melanoma	0.000744	0.000861	CcSEcCtD
Moxifloxacin—Constipation—Carmustine—melanoma	0.000744	0.000861	CcSEcCtD
Moxifloxacin—Dyspepsia—Temozolomide—melanoma	0.00074	0.000857	CcSEcCtD
Moxifloxacin—Eye disorder—Docetaxel—melanoma	0.000735	0.000851	CcSEcCtD
Moxifloxacin—Abdominal pain—Dactinomycin—melanoma	0.000735	0.000851	CcSEcCtD
Moxifloxacin—Body temperature increased—Dactinomycin—melanoma	0.000735	0.000851	CcSEcCtD
Moxifloxacin—Hypersensitivity—Bleomycin—melanoma	0.000734	0.00085	CcSEcCtD
Moxifloxacin—Decreased appetite—Temozolomide—melanoma	0.000731	0.000846	CcSEcCtD
Moxifloxacin—Cardiac disorder—Docetaxel—melanoma	0.00073	0.000846	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Temozolomide—melanoma	0.000726	0.00084	CcSEcCtD
Moxifloxacin—Fatigue—Temozolomide—melanoma	0.000725	0.000839	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000721	0.00633	CbGpPWpGaD
Moxifloxacin—Constipation—Temozolomide—melanoma	0.000719	0.000832	CcSEcCtD
Moxifloxacin—Pain—Temozolomide—melanoma	0.000719	0.000832	CcSEcCtD
Moxifloxacin—Feeling abnormal—Carmustine—melanoma	0.000717	0.00083	CcSEcCtD
Moxifloxacin—Asthenia—Bleomycin—melanoma	0.000715	0.000828	CcSEcCtD
Moxifloxacin—Angiopathy—Docetaxel—melanoma	0.000714	0.000827	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—melanoma	0.000712	0.00625	CbGpPWpGaD
Moxifloxacin—Gastrointestinal pain—Carmustine—melanoma	0.000711	0.000824	CcSEcCtD
Moxifloxacin—Immune system disorder—Docetaxel—melanoma	0.000711	0.000823	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Docetaxel—melanoma	0.000709	0.000821	CcSEcCtD
Moxifloxacin—Chills—Docetaxel—melanoma	0.000706	0.000818	CcSEcCtD
Moxifloxacin—Pruritus—Bleomycin—melanoma	0.000705	0.000816	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000705	0.00618	CbGpPWpGaD
Moxifloxacin—Arrhythmia—Docetaxel—melanoma	0.000703	0.000814	CcSEcCtD
Moxifloxacin—Feeling abnormal—Temozolomide—melanoma	0.000693	0.000802	CcSEcCtD
Moxifloxacin—Mental disorder—Docetaxel—melanoma	0.000689	0.000798	CcSEcCtD
Moxifloxacin—Abdominal pain—Carmustine—melanoma	0.000688	0.000796	CcSEcCtD
Moxifloxacin—Body temperature increased—Carmustine—melanoma	0.000688	0.000796	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Temozolomide—melanoma	0.000687	0.000796	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	0.000685	0.00601	CbGpPWpGaD
Moxifloxacin—Erythema—Docetaxel—melanoma	0.000685	0.000793	CcSEcCtD
Moxifloxacin—Malnutrition—Docetaxel—melanoma	0.000685	0.000793	CcSEcCtD
Moxifloxacin—Hypersensitivity—Dactinomycin—melanoma	0.000685	0.000793	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000677	0.00593	CbGpPWpGaD
Moxifloxacin—Dysgeusia—Docetaxel—melanoma	0.000671	0.000777	CcSEcCtD
Moxifloxacin—Urticaria—Temozolomide—melanoma	0.000668	0.000773	CcSEcCtD
Moxifloxacin—Asthenia—Dactinomycin—melanoma	0.000667	0.000772	CcSEcCtD
Moxifloxacin—Body temperature increased—Temozolomide—melanoma	0.000665	0.000769	CcSEcCtD
Moxifloxacin—Abdominal pain—Temozolomide—melanoma	0.000665	0.000769	CcSEcCtD
Moxifloxacin—Back pain—Docetaxel—melanoma	0.000663	0.000767	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000662	0.00581	CbGpPWpGaD
Moxifloxacin—Muscle spasms—Docetaxel—melanoma	0.000659	0.000763	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000655	0.00575	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—melanoma	0.000654	0.00573	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000649	0.00569	CbGpPWpGaD
Moxifloxacin—Hypersensitivity—Carmustine—melanoma	0.000641	0.000742	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000636	0.00558	CbGpPWpGaD
Moxifloxacin—Diarrhoea—Dactinomycin—melanoma	0.000636	0.000736	CcSEcCtD
Moxifloxacin—Vomiting—Bleomycin—melanoma	0.000634	0.000734	CcSEcCtD
Moxifloxacin—Anaemia—Docetaxel—melanoma	0.000633	0.000733	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	0.000633	0.00555	CbGpPWpGaD
Moxifloxacin—Rash—Bleomycin—melanoma	0.000628	0.000728	CcSEcCtD
Moxifloxacin—Dermatitis—Bleomycin—melanoma	0.000628	0.000727	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000624	0.00548	CbGpPWpGaD
Moxifloxacin—Asthenia—Carmustine—melanoma	0.000624	0.000723	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—melanoma	0.00062	0.00543	CbGpPWpGaD
Moxifloxacin—Hypersensitivity—Temozolomide—melanoma	0.000619	0.000717	CcSEcCtD
Moxifloxacin—Syncope—Docetaxel—melanoma	0.000614	0.000711	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000613	0.00538	CbGpPWpGaD
Moxifloxacin—Leukopenia—Docetaxel—melanoma	0.000613	0.00071	CcSEcCtD
Moxifloxacin—Palpitations—Docetaxel—melanoma	0.000605	0.000701	CcSEcCtD
Moxifloxacin—Asthenia—Temozolomide—melanoma	0.000603	0.000698	CcSEcCtD
Moxifloxacin—Loss of consciousness—Docetaxel—melanoma	0.000602	0.000697	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000601	0.00527	CbGpPWpGaD
Moxifloxacin—Cough—Docetaxel—melanoma	0.000598	0.000692	CcSEcCtD
Moxifloxacin—Diarrhoea—Carmustine—melanoma	0.000595	0.000689	CcSEcCtD
Moxifloxacin—Pruritus—Temozolomide—melanoma	0.000595	0.000689	CcSEcCtD
Moxifloxacin—Convulsion—Docetaxel—melanoma	0.000594	0.000687	CcSEcCtD
Moxifloxacin—Nausea—Bleomycin—melanoma	0.000592	0.000685	CcSEcCtD
Moxifloxacin—Hypertension—Docetaxel—melanoma	0.000591	0.000685	CcSEcCtD
Moxifloxacin—Vomiting—Dactinomycin—melanoma	0.000591	0.000684	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—FAS—melanoma	0.000589	0.00516	CbGpPWpGaD
Moxifloxacin—Rash—Dactinomycin—melanoma	0.000586	0.000679	CcSEcCtD
Moxifloxacin—Chest pain—Docetaxel—melanoma	0.000583	0.000675	CcSEcCtD
Moxifloxacin—Arthralgia—Docetaxel—melanoma	0.000583	0.000675	CcSEcCtD
Moxifloxacin—Myalgia—Docetaxel—melanoma	0.000583	0.000675	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000579	0.000671	CcSEcCtD
Moxifloxacin—Dizziness—Carmustine—melanoma	0.000575	0.000666	CcSEcCtD
Moxifloxacin—Diarrhoea—Temozolomide—melanoma	0.000575	0.000666	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000571	0.00501	CbGpPWpGaD
Moxifloxacin—Dry mouth—Docetaxel—melanoma	0.00057	0.00066	CcSEcCtD
Moxifloxacin—Confusional state—Docetaxel—melanoma	0.000564	0.000653	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Docetaxel—melanoma	0.000559	0.000647	CcSEcCtD
Moxifloxacin—Oedema—Docetaxel—melanoma	0.000559	0.000647	CcSEcCtD
Moxifloxacin—Dizziness—Temozolomide—melanoma	0.000556	0.000644	CcSEcCtD
Moxifloxacin—Vomiting—Carmustine—melanoma	0.000553	0.00064	CcSEcCtD
Moxifloxacin—Nausea—Dactinomycin—melanoma	0.000552	0.000639	CcSEcCtD
Moxifloxacin—Shock—Docetaxel—melanoma	0.00055	0.000637	CcSEcCtD
Moxifloxacin—Rash—Carmustine—melanoma	0.000549	0.000635	CcSEcCtD
Moxifloxacin—Nervous system disorder—Docetaxel—melanoma	0.000548	0.000635	CcSEcCtD
Moxifloxacin—Dermatitis—Carmustine—melanoma	0.000548	0.000634	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Docetaxel—melanoma	0.000547	0.000634	CcSEcCtD
Moxifloxacin—Tachycardia—Docetaxel—melanoma	0.000546	0.000632	CcSEcCtD
Moxifloxacin—Headache—Carmustine—melanoma	0.000545	0.000631	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—melanoma	0.000545	0.00478	CbGpPWpGaD
Moxifloxacin—Skin disorder—Docetaxel—melanoma	0.000543	0.000629	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000542	0.00475	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.00054	0.00473	CbGpPWpGaD
Moxifloxacin—Vomiting—Temozolomide—melanoma	0.000535	0.000619	CcSEcCtD
Moxifloxacin—Anorexia—Docetaxel—melanoma	0.000533	0.000617	CcSEcCtD
Moxifloxacin—Rash—Temozolomide—melanoma	0.00053	0.000614	CcSEcCtD
Moxifloxacin—Dermatitis—Temozolomide—melanoma	0.00053	0.000613	CcSEcCtD
Moxifloxacin—Headache—Temozolomide—melanoma	0.000527	0.00061	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—melanoma	0.000524	0.0046	CbGpPWpGaD
Moxifloxacin—Hypotension—Docetaxel—melanoma	0.000522	0.000605	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—CDK4—melanoma	0.000518	0.00454	CbGpPWpGaD
Moxifloxacin—Nausea—Carmustine—melanoma	0.000517	0.000598	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000509	0.00059	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—melanoma	0.000508	0.00446	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000508	0.00446	CbGpPWpGaD
Moxifloxacin—Insomnia—Docetaxel—melanoma	0.000506	0.000585	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—NOS2—melanoma	0.000504	0.00442	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000502	0.0044	CbGpPWpGaD
Moxifloxacin—Paraesthesia—Docetaxel—melanoma	0.000502	0.000581	CcSEcCtD
Moxifloxacin—Nausea—Temozolomide—melanoma	0.000499	0.000578	CcSEcCtD
Moxifloxacin—Dyspnoea—Docetaxel—melanoma	0.000498	0.000577	CcSEcCtD
Moxifloxacin—Somnolence—Docetaxel—melanoma	0.000497	0.000575	CcSEcCtD
Moxifloxacin—Dyspepsia—Docetaxel—melanoma	0.000492	0.00057	CcSEcCtD
Moxifloxacin—Decreased appetite—Docetaxel—melanoma	0.000486	0.000563	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Docetaxel—melanoma	0.000483	0.000559	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—melanoma	0.000482	0.00423	CbGpPWpGaD
Moxifloxacin—Fatigue—Docetaxel—melanoma	0.000482	0.000558	CcSEcCtD
Moxifloxacin—Constipation—Docetaxel—melanoma	0.000478	0.000554	CcSEcCtD
Moxifloxacin—Pain—Docetaxel—melanoma	0.000478	0.000554	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000473	0.00415	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PPARG—melanoma	0.000471	0.00413	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000465	0.00408	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—AURKA—melanoma	0.000465	0.00408	CbGpPWpGaD
Moxifloxacin—Feeling abnormal—Docetaxel—melanoma	0.000461	0.000533	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—melanoma	0.00046	0.00404	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MLH1—melanoma	0.00046	0.00403	CbGpPWpGaD
Moxifloxacin—Gastrointestinal pain—Docetaxel—melanoma	0.000457	0.000529	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—SKP2—melanoma	0.000455	0.00399	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.00045	0.00394	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—melanoma	0.000445	0.0039	CbGpPWpGaD
Moxifloxacin—Abdominal pain—Docetaxel—melanoma	0.000442	0.000512	CcSEcCtD
Moxifloxacin—Body temperature increased—Docetaxel—melanoma	0.000442	0.000512	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000431	0.00378	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000428	0.00375	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—AURKA—melanoma	0.000416	0.00365	CbGpPWpGaD
Moxifloxacin—Hypersensitivity—Docetaxel—melanoma	0.000412	0.000477	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000406	0.00356	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—APEX1—melanoma	0.000404	0.00354	CbGpPWpGaD
Moxifloxacin—Asthenia—Docetaxel—melanoma	0.000401	0.000464	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.0004	0.00351	CbGpPWpGaD
Moxifloxacin—Pruritus—Docetaxel—melanoma	0.000396	0.000458	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000395	0.00346	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000386	0.00338	CbGpPWpGaD
Moxifloxacin—Diarrhoea—Docetaxel—melanoma	0.000383	0.000443	CcSEcCtD
Moxifloxacin—Dizziness—Docetaxel—melanoma	0.00037	0.000428	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—melanoma	0.000369	0.00324	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000365	0.0032	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—APEX1—melanoma	0.000361	0.00317	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000358	0.00314	CbGpPWpGaD
Moxifloxacin—Vomiting—Docetaxel—melanoma	0.000355	0.000412	CcSEcCtD
Moxifloxacin—Rash—Docetaxel—melanoma	0.000353	0.000408	CcSEcCtD
Moxifloxacin—Dermatitis—Docetaxel—melanoma	0.000352	0.000408	CcSEcCtD
Moxifloxacin—Headache—Docetaxel—melanoma	0.00035	0.000406	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—melanoma	0.000349	0.00306	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000349	0.00306	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000345	0.00303	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000337	0.00296	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000336	0.00295	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000335	0.00294	CbGpPWpGaD
Moxifloxacin—Nausea—Docetaxel—melanoma	0.000332	0.000384	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—PTEN—melanoma	0.000323	0.00283	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—melanoma	0.000321	0.00281	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PRKCA—melanoma	0.000314	0.00275	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2B—melanoma	0.000312	0.00274	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000304	0.00267	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PCNA—melanoma	0.000302	0.00265	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000287	0.00252	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—E2F1—melanoma	0.000287	0.00251	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—PRKCA—melanoma	0.000281	0.00246	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.00028	0.00245	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—melanoma	0.000276	0.00242	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000274	0.0024	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000273	0.0024	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—PCNA—melanoma	0.00027	0.00237	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—melanoma	0.000261	0.00229	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TERT—melanoma	0.000261	0.00229	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.00026	0.00228	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000258	0.00227	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDK2—melanoma	0.000247	0.00217	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000237	0.00208	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—ATM—melanoma	0.000235	0.00206	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDK4—melanoma	0.000234	0.00205	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.00023	0.00201	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RB1—melanoma	0.000227	0.00199	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—melanoma	0.00022	0.00193	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RB1—melanoma	0.000203	0.00178	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—IL6—melanoma	0.000202	0.00177	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—melanoma	0.0002	0.00175	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000194	0.0017	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2A—melanoma	0.000179	0.00157	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—melanoma	0.000177	0.00155	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MDM2—melanoma	0.000173	0.00152	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—melanoma	0.000169	0.00148	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—melanoma	0.000163	0.00143	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1B—melanoma	0.000158	0.00139	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND1—melanoma	0.000151	0.00132	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1A—melanoma	0.000146	0.00128	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—melanoma	0.000139	0.00122	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYC—melanoma	0.000135	0.00119	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	0.000132	0.00116	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAPK3—melanoma	0.000124	0.00109	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MYC—melanoma	0.000121	0.00106	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAPK1—melanoma	0.000118	0.00104	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TP53—melanoma	9.94e-05	0.000872	CbGpPWpGaD
